Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.72M+117%$37.03M+4,201%$1.01M-$8.23M-$15.88M
$16M+14.3%$15.27M+12.1%$14.82M+14.1%$14.36M+20.1%$14M+29.3%
$13.57M+17.6%$13.3M+25.7%$11.87M+18.0%$11.51M+18.0%$11.54M+21.6%
-$33.18M-251%$4.44M-82.8%
$13.67M+19.5%$14.15M+41.1%$12.86M+28.7%$13.19M-1.6%$11.44M-39.9%
-$13.67M-19.5%-$14.15M-41.1%-$12.86M-28.7%-$13.19M+1.6%-$11.44M+39.9%
-$35.52M-226%-$17.36M-163%$21.1M+371%$29.63M+492%$28.19M+510%
-$30.55M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Organogenesis Holdings Inc. generate?
Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
What is Organogenesis Holdings Inc.'s free cash flow?
After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
Where does Organogenesis Holdings Inc.'s cash flow data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.